Landos Biopharma
Patents, Design & Utilities
Last updated:
List of all Landos Biopharma patents 26 in total
| Status | Patent |
|---|---|
Application | Utility: LANTHIONINE C-LIKE PROTEIN 2 LIGANDS, CELLS PREPARED THEREWITH, AND THERAPIES USING SAME Filling date: 5 Sep 2025 Issue date: 1 Sep 2022 |
Grant | Utility: Lanthionine C-like protein 2 ligands, cells prepared therewith, and therapies using same Filling date: 5 Sep 2025 Issue date: 5 Jul 2022 |
Application | Utility: COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING INFLAMMATORY OR IMMUNE-MEDIATED CONDITIONS OF SURFACE TISSUES Filling date: 5 Sep 2025 Issue date: 19 May 2022 |
Application | Utility: CRYSTALLINE FORMS OF PIPERAZINE-1,4-DIYLBIS((6-(1H-BENZO[D]IMIDAZO-2-YL)PYRIDIN-2YL)METHANONE) Filling date: 5 Sep 2025 Issue date: 5 May 2022 |
Application | Utility: LANCL LIGANDS Filling date: 5 Sep 2025 Issue date: 28 Apr 2022 |
Application | Utility: NLRX1 LIGANDS Filling date: 5 Sep 2025 Issue date: 24 Mar 2022 |
Application | Utility: THERAPIES WITH LANTHIONINE C-LIKE PROTEIN 2 LIGANDS AND CELLS PREPARED THEREWITH Filling date: 5 Sep 2025 Issue date: 10 Mar 2022 |
Application | Utility: PLXDC2 LIGANDS Filling date: 5 Sep 2025 Issue date: 20 Jan 2022 |
Grant | Utility: Therapies with lanthionine C-like protein 2 ligands and cells prepared therewith Filling date: 5 Sep 2025 Issue date: 14 Dec 2021 |
Grant | Utility: PLXDC2 ligands Filling date: 5 Sep 2025 Issue date: 23 Nov 2021 |
Application | Utility: LANTHIONINE C-LIKE PROTEIN 2 LIGANDS, CELLS PREPARED THEREWITH, AND THERAPIES USING SAME Filling date: 5 Sep 2025 Issue date: 18 Nov 2021 |
Application | Utility: NLRX1 LIGANDS Filling date: 5 Sep 2025 Issue date: 7 Oct 2021 |
Application | Utility: PLXDC2 LIGANDS Filling date: 5 Sep 2025 Issue date: 7 Oct 2021 |
Grant | Utility: Lanthionine c-like protein 2 ligands, cells prepared therewith, and therapies using same Filling date: 5 Sep 2025 Issue date: 14 Sep 2021 |
Grant | Utility: NLRX1 ligands Filling date: 5 Sep 2025 Issue date: 20 Jul 2021 |
Application | Utility: LANTHIONINE C-LIKE PROTEIN 2 LIGANDS, CELLS PREPARED THEREWITH, AND THERAPIES USING SAME Filling date: 5 Sep 2025 Issue date: 24 Jun 2021 |
Application | Utility: LANTHIONINE SYNTHETASE C-LIKE 2-BASED THERAPEUTICS Filling date: 5 Sep 2025 Issue date: 18 Feb 2021 |
Grant | Utility: Lanthionine synthetase C-like 2-based therapeutics Filling date: 5 Sep 2025 Issue date: 1 Dec 2020 |
Application | Utility: LANTHIONINE SYNTHETASE C-LIKE 2-BASED THERAPEUTICS Filling date: 5 Sep 2025 Issue date: 20 Aug 2020 |
Application | Utility: NLRX1 LIGANDS Filling date: 5 Sep 2025 Issue date: 13 Aug 2020 |
Grant | Utility: Lanthionine synthetase C-like 2-based therapeutics Filling date: 5 Sep 2025 Issue date: 16 Jun 2020 |
Grant | Utility: NLRX1 ligands Filling date: 5 Sep 2025 Issue date: 9 Jun 2020 |
Application | Utility: LANTHIONINE SYNTHETASE C-LIKE 2-BASED THERAPEUTICS Filling date: 5 Sep 2025 Issue date: 13 Feb 2020 |
Application | Utility: NLRX1 LIGANDS Filling date: 5 Sep 2025 Issue date: 9 Jan 2020 |
Grant | Utility: Lanthionine synthetase C-like 2-based therapeutics Filling date: 5 Sep 2025 Issue date: 3 Dec 2019 |
Grant | Utility: NLRX1 ligands Filling date: 5 Sep 2025 Issue date: 26 Nov 2019 |
Showing 1 to 26 of 26 patents.